Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Treatment for Patients
.
Show all posts
Showing posts with label
Treatment for Patients
.
Show all posts
Tuesday, February 17, 2026
FDA Files Corcept’s New Drug Application for Relacorilant as a Treatment for Patients with Platinum-Resistant Ovarian Cancer
›
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to trea...
›
Home
View web version
